Stock LCTX LINEAGE CELL THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Lineage Cell Therapeutics, Inc.

Equities

LCTX

US53566P1093

Market Closed - Nyse
Other stock markets
 16:00:00 2024-06-05 EDT 		5-day change 1st Jan Change
0.9753 USD +0.28% Intraday chart for Lineage Cell Therapeutics, Inc. +4.87% -10.52%
05-21 Lineage Cell Therapeutics, Inc. Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium CI
05-09 Transcript : Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
LINEAGE CELL THERAPEUTICS, INC. Stock Lineage Cell Therapeutics, Inc.
 184M - - -
MODERNA, INC. Stock Moderna, Inc.
 55.7B -
LONZA GROUP AG Stock Lonza Group AG
 39.91B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 39.57B
CELLTRION, INC. Stock Celltrion, Inc.
 28.16B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.3B
  1. Stock Market
  2. Equities
  3. LCTX Stock
  4. Charts Lineage Cell Therapeutics, Inc.
  5. Sector Chart